Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.

    Hamdan Bin Rashid Al Maktoum Foundation for Medical and Educational Sciences celebrated the UAE’s 54th Eid Al Etihad through a comprehensive national event inspired by the spirit of its previous commemorations and reflecting the values of the Union and the Emirati identity in their finest form. The Foundation hosted the celebration at its headquarters in […] The post Hamdan Bin Rashid Al Maktoum Foundation Celebrates the 54th Eid Al Etihad appeared first on Web-Release.